Tag

Rsv Vaccine

All articles tagged with #rsv vaccine

health1 month ago•5 min saved

ACOG Announces Independent Maternal Vaccination Schedule, Distancing from CDC Guidance

ACOG issued its first official maternal vaccination schedule, recommending vaccines during pregnancy for influenza, COVID-19, Tdap, and RSV—and, for some individuals, hepatitis B or MMR—marking a break from prior alignment with federal CDC/ACIP guidance. Supported by about 13 medical societies, the guidance aims to provide clear, evidence-based information amid vaccine misinformation and hesitancy, and the article notes real-world data showing RSV vaccination during pregnancy is 68% effective at preventing hospitalization in infants under three months.

via The Guardian|

#acog #cdc #health

health1 month ago•10 min saved

Lawsuit Alleges NIH Used Black Infants in Secret RSV Vaccine Trials

A federal lawsuit filed by Ben Crump accuses the NIH of secretly injecting two healthy Black infants with an experimental RSV vaccine in the 1960s without parental consent, leading to the infants’ deaths and later use of preserved tissues to develop the vaccine now in use; the filing frames the case as racial exploitation and seeks accountability.

via The Root|

#health #informed-consent #lawsuit

health6 months ago•0 min saved

U.S. Simplifies Childhood Vaccine Schedule, Reducing Shots and Diseases Covered

The US has revised its childhood vaccine schedule, now recommending fewer vaccines for flu, hepatitis A and B, and RSV, aligning with peer countries, and bypassing the usual approval process, under Health Secretary Robert F. Kennedy Jr.'s initiatives.

via The Washington Post|

#childhood-vaccines #flu-vaccine #health

health9 months ago•5 min saved

Vaccines May Lower Dementia Risk: What You Need to Know

Emerging evidence suggests that vaccines, especially the shingles vaccine, may reduce the risk of dementia by preventing infections that accelerate brain aging and possibly through immune system stimulation, offering a promising new avenue for dementia prevention alongside lifestyle changes.

via ZME Science|

#dementia #health #preventive-health

health10 months ago•2 min saved

Ob/Gyn Group Recommends COVID-19 Vaccination for Pregnant Women

The American College of Obstetricians and Gynecologists (ACOG) recommends COVID-19, flu, and RSV vaccines for pregnant women, diverging from CDC guidance, emphasizing the safety and protective benefits of vaccination during pregnancy to reduce severe illness and protect newborns, especially during the upcoming respiratory season.

via CIDRAP|

#acog #covid-19-vaccination #flu-vaccine

health11 months ago•5 min saved

OB-GYNs Endorse COVID-19 Vaccines for Pregnant Women Amidst Federal and State Debates

The American College of Obstetricians and Gynecologists (ACOG) has updated its guidelines to strongly recommend vaccination during pregnancy against COVID-19, influenza, and RSV, emphasizing the safety and benefits of maternal immunization for protecting both mothers and infants, including passive immunity for newborns and reduced pregnancy complications.

via ACOG|

#covid-19-vaccine #health #influenza-vaccine

health1 year ago•6 min saved

New RSV Prevention Strategies Reduce Infant Illnesses

A UK study shows that vaccinating pregnant women against RSV results in a 72% decrease in severe RSV hospitalizations in infants by transferring protective antibodies through the placenta, highlighting the importance of increasing vaccination rates among expectant mothers to protect newborns during the winter season.

via SciTechDaily|

#health #hospitalization-reduction #infant-health

health1 year ago•3 min saved

Study Finds Two Vaccines May Lower Dementia Risk

A large US study suggests that the shingles vaccine (Shingrix) and the RSV vaccine (Arexyv) are associated with a reduced risk of dementia in older adults, potentially due to the immune-boosting adjuvant they contain, indicating vaccines might protect against cognitive decline beyond preventing specific viruses.

via ScienceAlert|

#dementia #health #immune-system

health1 year ago•2 min saved

CDC Expands RSV Vaccine Recommendations Amid Market Gains

Health Secretary Robert F. Kennedy Jr. approved an expansion of CDC's RSV vaccine recommendations to include adults aged 50-59 at high risk, after firing the original advisory committee members. This move benefits vaccine makers Moderna and Pfizer, whose shares rose following the announcement, and reflects ongoing vaccine regulation despite Kennedy's disruptions to the public health apparatus.

via Barron's|

#cdc #health #kennedy

business1 year ago•1 min saved

Recent Developments in RSV and Vaccine Recommendations

Moderna's stock rose after CDC recommended its RSV vaccine for at-risk adults aged 50-59, aligning with previous advisory panel recommendations, despite earlier uncertainties following Robert F. Kennedy Jr.'s decision to replace the advisory panel. This expands Moderna's market for the vaccine, which competes with Pfizer and GSK, and signals potential future growth despite past sales misses.

via Investor's Business Daily|

#business #cdc #kennedy

health1 year ago•2 min saved

FDA Approves Moderna's RSV Vaccine for Adults Under 60 Amid Industry Uncertainty

The FDA has expanded Moderna's RSV vaccine approval to include adults under 60 at increased risk, pending CDC advisory committee approval, marking a significant step in protecting more vulnerable populations from severe RSV illness.

via ABC News|

#adults-under-60 #fda-approval #health

business1 year ago•4 min saved

Moderna Surprises with Profit Amid Uncertain Future

Moderna reported a surprise profit in the third quarter, driven by strong Covid vaccine sales, but its stock fell after initial gains. The company's RSV vaccine sales were significantly below expectations, contributing to a cautious outlook. Despite the unexpected profit, analysts predict continued losses as Moderna invests in its product portfolio. The company plans to seek FDA approval for new vaccines but faces challenges in a competitive market. Moderna's stock has declined significantly since its peak earlier this year.

via Investor's Business Daily|

#business #covid-vaccine #financial-performance

business1 year ago•2 min saved

Moderna Surprises with Profit Amid Strong COVID Vaccine Sales

Moderna reported a surprise third-quarter profit of $13 million, driven by higher-than-expected sales of its COVID-19 vaccine, Spikevax, which generated $1.8 billion in revenue. This exceeded analysts' expectations and marked a significant turnaround from a $3.6 billion loss a year ago. Despite the profit, Moderna anticipates lower COVID vaccine sales this year compared to 2023 and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. Sales of its new RSV vaccine fell short of expectations, contributing only $10 million.

via Yahoo Finance|

#business #covid-19-vaccine #financial-results

business1 year ago•3 min saved

Moderna's Unexpected Profit Boosts Stock Amid Uncertain Future

Moderna reported a surprise profit of $13 million for the third quarter, driven by higher-than-expected Covid vaccine sales and significant cost-cutting measures. The company's revenue reached $1.86 billion, surpassing Wall Street expectations. Moderna's efforts to reduce expenses include a goal of saving $1.1 billion by 2027. The quarter also marked the first sales of its RSV vaccine, though these were lower than anticipated. Moderna plans to expand its product offerings, including a next-generation Covid vaccine and a combination shot targeting Covid and flu.

via CNBC|

#business #cost-cutting #covid-vaccine

health2 years ago•2 min saved

FDA Approves Moderna's RSV Vaccine for Seniors

The US FDA has approved Moderna's RSV vaccine, mRESVIA, for adults aged 60 and older, with a label indicating 79% efficacy, lower than the 84% initially reported. This approval marks the first non-COVID-19 mRNA vaccine in the US. Moderna aims to generate new revenue as demand for its COVID-19 vaccine declines, with analysts forecasting significant sales growth for the RSV vaccine in the coming years. The CDC will vote on usage recommendations next month.

via Reuters|

#efficacy #fda #health